Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

Successful Early Discharge and Avoided Hospitalization for Methicillin-Resistant Staphylococcus aureus Infections Treated With Outpatient Parenteral Antimicrobial Therapy Result in Healthcare Cost Savings

Background. Methicillin-resistant Staphylococcus aureus (MRSA) infections cause over $3 billion in annual hospital costs. They were responsible for 48% of hospital-acquired infections in 2014, for which the federal government will penalize hospitals beginning in 2017....

Successful, Cost-Saving Outpatient Parenteral Antimicrobial Therapy (OPAT) Following Hospital Discharge: Early Pilot Study of an Indigent Healthcare Program between a Physician Office Infusion Center (POIC) and Two Tucson Hospitals

Authors: Richard M. Mandel, MD, – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ Clifford P. Martin, MD – Southern Arizona Infectious Disease Specialists, PLC, Tucson, AZ Thuy N. Sixt, PharmD, -Healix Infusion Therapy, Inc. Sugar Land, TX...